Comparative characteristics of pneumonia caused by Mycoplasma pneumoniae in children

The urgency of the problem of community-acquired pneumonia in children is due to the high incidence rate. In the etiological structure of bacterial pneumonia, Streptococcus pneumoniae and Mycoplasma pneumonia (Mp) prevail.

Purpose: to identify clinical, laboratory and instrumental features of mycoplasmal pneumonia in children.

Materials and methods. A retrospective,  single-center cohort study  of  266  case  histories  of  children  aged  4 months to 17 years who were in Children’s City Clinical Hospital No. 9 in 2019 with a referral diagnosis of pneumonia was carried out. To verify the diagnosis of pneumonia, the method of chest X-ray was used, for the etiological diagnosis, the method of PCR swabs from the nasopharynx, ELISA for the detection of antibodies of the IgM and IgG classes was used. Results. The diagnosis  of  pneumonia was confirmed in 190 children. The diagnosis of pneumonia caused by M. pneumoniae (MpP) was established in 76 (40%) children, they made up the 1st group. The remaining 114 (60%) children with community-acquired pneumonia of another etiology (CAP) made up the 2nd group – comparisons. The diagnosis of MpP was confirmed in 46 (60.5%) children by the detection of IgM, in 12 (15.8%) by the detection of Mp genetic material, and in  18  (23.7%) by positive both IgM and PCR. The median age of children in the group with MpP was 9.6 years, in the comparison group – 4 years (p<0.01). Significantly more often MpP occurs in children aged 11–17 years (p < 0.01), and CAP – up to 7 years (p < 0.01). With MpP, catarrhal phenomena in the form of hyperemia of the oropharynx, nasal congestion, and unproductive cough are observed less frequently than with CAP. With MpP, rales in the lungs are heard more often than with CAP, they are significantly more often wet (p<0.01). Respiratory failure and dyspnea are less common in MpP than in CAP. Bilateral lesions and lesions of the upper lobe of the lungs are more often detected in MpP, and in CAP – right-sided lesions. In the general blood test, leukocytosis, incl. above 15  thousand/µl,  as well as leukopenia below 4 thousand/µl were significantly more frequent in the group of patients with CAP (p<0.01). Conclusion. No clear clinical and laboratory criteria for mycoplasmal etiology of pneumonia have been obtained, which dictates the need for laboratory confirmation for the choice of therapy tactics.

1. On the state of sanitary and epidemiological well-being of the population in the Russian Federation in 2019: State report. M., 2020:299. (In Russ.)

2. Yun K.W., Wallihan R., Desai A., Alter S. et al. Clinical Characteristics and Etiology of Community-acquired Pneumonia in US Children, 2015–2018. The Pediatric Infectious Disease Journal. 2022; 41(5):381-387. doi: 10.1097/INF.0000000000003475

3. Oumei H., Xuefeng W., Jianping .L, Kunling S. еt al. Etiology of community-acquired pneumonia in 1500 hospitalized children. J Med Virol. 2018 Mar; 90(3):421-428. doi: 10.1002/jmv.24963

4. Preeta K Kutty, Seema Jain, Thomas H Taylor, Anna M Bramley et al. Mycoplasma pneumoniae Among Children Hospitalized With Community-acquired Pneumonia. Clin Infect Dis. 2019 Jan 1; 68(1):5-12. doi: 10.1093/cid/ciy419.

5. Surinder Kumar. Mycoplasma pneumoniae: A significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections. Indian J Med Res. 2018 Jan; 147(1):23-31. doi: 10.4103/ijmr.IJMR_1582_16.

6. Jain S., Williams D.J., Arnold S.R. Community-acquired pneumonia requiring hospitalization among US children. N Engl J Med. 2015; 372(9):835–845.

7. Biljana Medjo, Marina Atanaskovic-Markovic, Snezana Radic, Dimitrije Nikolic, Marija Lukac, Slobodanka Djukic. Mycoplasma pneumoniae as a causative agent of community-acquired pneumonia in children: clinical features and laboratory diagnosis. Ital J Pediatr. 2014 Dec 18; 40:104. doi: 10.1186/s13052-014-0104-4.

8. Atamna A., Shiber S., Yassin M., Drescher M.J., Bishara J. The accuracy of a diagnosis of pneumonia in the emergency department. Int J Infect Dis. 2019 Dec; 89:62-65. doi: 10.1016/j.ijid.2019.08.027.

9. Spuesens E.B., Fraaij P.L, Visser E.G, Hoogenboezem T. et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013; 10(5):e1001444. doi: 10.1371/journal.pmed.1001444.

10. Kannan T.R., Baseman J.B. ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens. Proc Natl Acad Sci USA. 2006; 103:6724–6729.

11. Clinical guidelines. Pneumonia (community-acquired). Ministry of Health of the Russian Federation. 2022:82. (In Russ.)

12. Tatochenko V.K. Respiratory diseases in children: A practical guide. 7th revised and enlarged edition, Moscow, 2019:300. (In Russ.)

13. Sobolenkova V.S., Fedorov S.Yu. On the issue of over-diagnosis of pneumonia in children in primary care. Detskie Infektsii=Children’s infections. 2021; 20(3):55-57. (In Russ.)

14. Girina A.A., Zaplatnikov A.L., Kovaleva A.V. [and others] Overdiagnosis of community-acquired pneumonia in children and ways to overcome it. Pediatria n.a. G.N. Speransky. 2018; 97(2): 50-54. (In Russ.). DOI 10.24110/0031-403X-2018-97-2-50-54.